Your browser doesn't support javascript.
loading
Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870).
Pili, Roberto; Quinn, David I; Hammers, Hans J; Monk, Paul; George, Saby; Dorff, Tanya B; Olencki, Thomas; Shen, Li; Orillion, Ashley; Lamonica, Dominick; Fragomeni, Roberto S; Szabo, Zsolt; Hutson, Alan; Groman, Adrienne; Perkins, Susan M; Piekarz, Richard; Carducci, Michael A.
Afiliación
  • Pili R; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. rpili@iu.edu.
  • Quinn DI; USC Norris Comprehensive Cancer Center, Los Angeles, California.
  • Hammers HJ; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
  • Monk P; The Ohio State University, Columbus, Ohio.
  • George S; Roswell Park Cancer Institute, Buffalo, New York.
  • Dorff TB; USC Norris Comprehensive Cancer Center, Los Angeles, California.
  • Olencki T; The Ohio State University, Columbus, Ohio.
  • Shen L; Roswell Park Cancer Institute, Buffalo, New York.
  • Orillion A; Roswell Park Cancer Institute, Buffalo, New York.
  • Lamonica D; Roswell Park Cancer Institute, Buffalo, New York.
  • Fragomeni RS; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
  • Szabo Z; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
  • Hutson A; Roswell Park Cancer Institute, Buffalo, New York.
  • Groman A; Roswell Park Cancer Institute, Buffalo, New York.
  • Perkins SM; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana.
  • Piekarz R; Cancer Therapy Evaluation Program, NCI, NI H, Bethesda, Maryland.
  • Carducci MA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
Clin Cancer Res ; 23(23): 7199-7208, 2017 Dec 01.
Article en En | MEDLINE | ID: mdl-28939740
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Protocolos de Quimioterapia Combinada Antineoplásica / Inmunomodulación / Neoplasias Renales Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Protocolos de Quimioterapia Combinada Antineoplásica / Inmunomodulación / Neoplasias Renales Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article